Answers are grounded in this paper and cite their sources.
Somatic mutations are important factors in tumorigenesis.In this issue of Blood, Zhang et al have identified recurrent mutations in key signaling pathways in highrisk childhood B-cell precursor acute lymphoblastic leukemia (BCP-ALL) to be exploited in the development of new therapeutic approaches. 1
No takes yet. Share an insight, caveat, or question.
Christine J. Harrison (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: